Policy Recommendations for Strengthening the Accelerated Approval Program for Oncology Drugs
Memo: Delivered to the U.S. Food and Drug Administration (FDA)
Population Health
Policy
Restricting Youth Access to Nicotine and Tobacco Products
Testimony: Delivered to Philadelphia City Council
Print:
In March 2025, LDI Senior Fellow Andy Tan, PhD, MPH testified before the Philadelphia City Council Committees on Public Safety and Public Health and Human Services in support of Bill 250213, which would increase the penalties for retailers who sell electronic smoking devices and unapproved nicotine delivery products to minors. Dr. Tan’s testimony highlighted research on youth access to tobacco and nicotine in Philadelphia and beyond, the benefits of restricting tobacco access through retailer fines, and suggestions for equitable implementation of the bill.
More on Policy at LDI
Estimated Overdose Deaths Due to the One Big Beautiful Bill Act
Research Memo: Delivered to House Speaker Mike Johnson and Majority Leader John Thune
Health Impacts of SNAP Provisions in the One Big Beautiful Bill Act
Research Memo: Delivered to House Speaker Mike Johnson and Majority Leader John Thune
Projected Mortality Impacts of the Budget Reconciliation Bill
Research Memo: Response to Request for Technical Assistance
Loss of Subsidized Drug Coverage and Mortality Following Medicaid Disenrollment: Translating our Findings and Implications for Medicaid Policy
Research Memo: Supplement to Response to Request for Technical Assistance
Medicaid’s Role in Health and the Health Care Landscape: Key Takeaways from LDI Researchers
Research Memo: Delivered to Staff of U.S. Senate Committee on Finance